Top 10 Orphan Drugs in the USA
The Top 10 bestselling orphan drugs in the USA in 2017. Celgene’s Revlimid (generic name lenolidamide) leads…
Facts
Top 10 Global Orphan Drug Companies Ranking
The top 10 companies in the world ranked by global orphan drug sales and market share in 2017. Swiss giants…
Orphan Drugs in Europe: A Snapshot
125 medicines for rare diseases were approved by the EMA between 2004 and 2014, of which 71 were granted orphan…
Orphan Drugs in the USA: A Snapshot
80 orphan drugs (those drugs intended to treat diseases so rare that sponsors are reluctant to develop them under…
Malaysia Pharma Market Snapshot
The growth of the Malaysian pharma market between 2006 and 2016. Pharmaceutical sales grew to over USD 2 billion by…
China Pharma Forecast 2019-2023
China has expanded to be the second largest pharmaceutical market globally with USD 137 billion in total spending…
Turkish Pharma: Imports & Exports Snapshot
Imports and exports in Turkish pharma between 2010 and 2017. Pharmaceutical exports grew to a total of USD 898…
Top 20 Pharma Companies in France (2018)
The Top 20 pharma companies in France, ranked by total turnover at ex-manufacturer prices for 2018. Swiss giant…
Egyptian Pharma Market Snapshot
The Egyptian pharma market grew at a compound annual growth rate (CAGR) of 17 percent between 2011 and 2017 to…
New Drugs Approved in the USA 2018
59 novel drugs were approved in the USA in 2018, representing a leap from the 46 approved in 2017 and 22 approved…
Clinical Trials in Korea: Top Facts
An outline of the geographical distribution of clinical trial sites in South Korea. 184 medical institutions were…
New Drugs Approved in Canada 2018
In total there were 27 new active substances (NASs) approved in Canada in 2018, 18 prescription pharmaceutical…